Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPS-J: Calblock vs Norvasc on Coronary Atherosclerosis
NCT00294567Phase 4Completed
- Sponsor
- Juntendo University
- Start
- Dec 2005
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Azelnidipine in hypertension (HTN), Coronary atherosclerosis (CAD), sponsored by Juntendo University. Started Dec 2005; status: completed.
02
Drugs
Azelnidipine
03
Conditions
hypertension (HTN)Coronary atherosclerosis (CAD)
Beyond the preview
Go deeper on NCT00294567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294567.